Bispecific antibody against human c-met and human EGFR, and use thereof
WO2025247296A9PCT designated stage Publication Date: 2026-01-22IMBIORAY (HANGZHOU) BIOMEDICINE CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PCT/CN2025/097888
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-05-30
- Filing Date
- 2025-05-29
- Publication Date
- 2026-01-22
Smart Images
Figure CN2025097888_22012026_PF_FP_ABST
Abstract
Provided in the present application is a bispecific antibody, which contains a first antigen-binding fragment against a human mesenchymal-epithelial transition factor (c-Met) and a second antigen-binding fragment against a human epidermal growth factor receptor (EGFR). In addition, further provided in the present application is the medical and biological use of the bispecific antibody.
Need to check novelty before this filing date? Find Prior Art